DragoJ.R.: Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Urology, 4; 187 (1989).
2.
GutmanA.B., GutmanE.B.: An “acid” phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostatic gland. J. Clin. Invest., 17; 473 (1938).
3.
HellerJ.E.: Prostatic acid phosphatase: Its currents clinical status. J. Urol., 137; 1091 (1987).
4.
HetheringtonJ.W., SiddalJ.K., CooperE.H.: Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer. Eur. Urol., 14; 1 (1988).
5.
StameyT.A.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med., 317; 909 (1987).
6.
WangM.C., ValenzuelaL.A., MurphyG.P., ChuT.M.: Purification of a human prostate-specific antigen. Invest. Urol., 17; 159 (1979).
